GEN1047 for Solid Tumors - First in Human (FIH) Trial
Genmab
Genmab
Conjupro Biotherapeutics, Inc.
Sotio Biotech Inc.
Genmab
Ocellaris Pharma, Inc.
Seagen Inc.
Fusion Pharmaceuticals Inc.
Bolt Biotherapeutics, Inc.
Pfizer
Nuvation Bio Inc.
Incyte Corporation
Actym Therapeutics, Inc.
NiKang Therapeutics, Inc.
Numab Therapeutics AG
University of Virginia
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
M.D. Anderson Cancer Center
Numab Therapeutics AG
Pfizer
NextCure, Inc.
Elevation Oncology
Valerio Therapeutics
Seagen Inc.
Deciphera Pharmaceuticals, LLC
Deciphera Pharmaceuticals, LLC
Aminex Therapeutics, Inc.
Novartis
Five Prime Therapeutics, Inc.
Tango Therapeutics, Inc.
NantCell, Inc.
ADC Therapeutics S.A.
Medikine, Inc.
Ikena Oncology
Haihe Biopharma Co., Ltd.
Gilead Sciences
pharmaand GmbH
CytomX Therapeutics
Atreca, Inc.
Fusion Pharmaceuticals Inc.
Leap Therapeutics, Inc.
pharmaand GmbH
Fate Therapeutics
Hoffmann-La Roche
Tesaro, Inc.
National Institutes of Health Clinical Center (CC)
Duke University
MacroGenics
University of Pennsylvania
Dr. Horst Schmidt Klinik GmbH